Certolizumab (Anti-TNFSF2 / TNFa)

Certolizumab (anti-TNFSF2 / TNFa) is a Fab fragment of a recombinant, humanized monoclonal antibody directed against the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) with anti-inflammatory activity. MW: 144.92 kD.

• Supplier: Selleck Chemicals
• Product #: A2798
• Sku #: A2798-1mg*25